Nme2 (NME/NM23 nucleoside diphosphate kinase 2) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Nme2 (NME/NM23 nucleoside diphosphate kinase 2) Rattus norvegicus
Analyze
Symbol: Nme2
Name: NME/NM23 nucleoside diphosphate kinase 2
RGD ID: 619877
Description: Enables several functions, including identical protein binding activity; intermediate filament binding activity; and kinase activity. Involved in several processes, including cellular response to glucose stimulus; response to growth hormone; and ribonucleoside triphosphate biosynthetic process. Located in mitochondrial membrane and perinuclear region of cytoplasm. Colocalizes with intermediate filament. Human ortholog(s) of this gene implicated in teratoma. Orthologous to several human genes including NME2 (NME/NM23 nucleoside diphosphate kinase 2); PARTICIPATES IN adefovir pharmacokinetics pathway; de novo pyrimidine biosynthetic pathway; Glut1 deficiency syndrome pathway; INTERACTS WITH 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine; 4,4'-sulfonyldiphenol.
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: expressed in non-metastatic cells 2; histidine protein kinase NDKB; NDK B; NDKB; NDP kinase alpha; NDP kinase B; nm23-2; non-metastatic cells 2, protein (NM23B) expressed in; nucleoside diphosphate kinase; nucleoside diphosphate kinase B; P18; p18-12d
RGD Orthologs
Human
Mouse
Bonobo
Dog
Squirrel
Pig
Green Monkey
Alliance Genes
More Info more info ...
Related Pseudogenes: Nme2-ps1  
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81079,394,999 - 79,400,418 (-)NCBIGRCr8
mRatBN7.21078,898,097 - 78,903,514 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1078,897,770 - 78,903,538 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1083,508,941 - 83,514,439 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01083,007,040 - 83,012,538 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01078,478,407 - 78,483,899 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01081,648,216 - 81,653,717 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1081,648,216 - 81,653,717 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01081,478,178 - 81,483,679 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41082,582,766 - 82,588,269 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11082,597,135 - 82,602,639 (-)NCBI
Celera1077,694,496 - 77,700,026 (-)NCBICelera
Cytogenetic Map10q26NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-catechin  (ISO)
1,2-dimethylhydrazine  (ISO)
17beta-estradiol  (EXP)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,4,6-tribromophenol  (ISO)
3,3',5,5'-tetrabromobisphenol A  (ISO)
4,4'-diaminodiphenylmethane  (ISO)
4,4'-sulfonyldiphenol  (EXP)
4-hydroxynon-2-enal  (ISO)
5-aza-2'-deoxycytidine  (ISO)
5-azacytidine  (EXP)
5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole  (EXP)
6-propyl-2-thiouracil  (EXP)
9-cis-retinoic acid  (ISO)
all-trans-retinoic acid  (ISO)
amiodarone  (EXP)
amitrole  (EXP)
ammonium chloride  (EXP)
arsenite(3-)  (ISO)
astaxanthin  (ISO)
benzbromarone  (EXP)
benzo[a]pyrene  (ISO)
bisphenol A  (EXP,ISO)
bisphenol F  (EXP)
bleomycin A2  (EXP)
cadmium dichloride  (EXP,ISO)
caffeine  (ISO)
calcitriol  (ISO)
cannabidiol  (ISO)
capsaicin  (ISO)
carbon nanotube  (ISO)
choline  (ISO)
clofibrate  (EXP)
clofibric acid  (EXP)
cocaine  (ISO)
cromoglycate(2-)  (EXP)
Cuprizon  (ISO)
decabromodiphenyl ether  (ISO)
dexamethasone  (ISO)
dextran sulfate  (ISO)
dibutyl phthalate  (EXP)
dichlorine  (EXP)
diethylstilbestrol  (ISO)
disodium selenite  (ISO)
doxorubicin  (ISO)
endosulfan  (EXP)
ethanol  (EXP)
fentin chloride  (ISO)
flutamide  (EXP)
folic acid  (ISO)
gentamycin  (EXP)
glafenine  (EXP)
glyphosate  (ISO)
hyaluronic acid  (EXP)
hydrogen peroxide  (EXP)
indometacin  (EXP)
L-ethionine  (EXP)
L-methionine  (ISO)
lithium atom  (EXP)
lithium hydride  (EXP)
Mesaconitine  (EXP)
methimazole  (EXP)
methylmercury chloride  (ISO)
mifepristone  (ISO)
N-nitrosodiethylamine  (EXP,ISO)
Nonylphenol  (EXP)
ochratoxin A  (ISO)
omeprazole  (EXP)
ozone  (EXP,ISO)
paracetamol  (EXP,ISO)
paraquat  (EXP)
PCB138  (EXP)
pirinixic acid  (EXP)
pregnenolone 16alpha-carbonitrile  (ISO)
progesterone  (ISO)
propiconazole  (EXP)
pyrimidifen  (ISO)
quinoline  (ISO)
rotenone  (ISO)
sarin  (EXP)
silicon dioxide  (ISO)
sodium arsenite  (ISO)
sodium dodecyl sulfate  (ISO)
sulfadimethoxine  (EXP)
T-2 toxin  (EXP)
tebufenpyrad  (ISO)
tert-butyl hydroperoxide  (ISO)
testosterone  (ISO)
tetrachloroethene  (ISO)
thapsigargin  (EXP)
thioacetamide  (EXP)
titanium dioxide  (ISO)
tributylstannane  (ISO)
triphenylstannane  (ISO)
trovafloxacin  (EXP)
tungsten  (ISO)
vinclozolin  (EXP)
zinc atom  (EXP)
zinc(0)  (EXP)

Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component

Phenotype Annotations     Click to see Annotation Detail View

Mammalian Phenotype
References

References - curated
# Reference Title Reference Citation
1. Inhibition of nucleoside diphosphate kinase (NDPK/nm23) by cAMP analogues. Anciaux K, etal., FEBS Lett. 1997 Jan 2;400(1):75-9.
2. Interactions of phocein with nucleoside-diphosphate kinase, Eps15, and Dynamin I. Baillat G, etal., J Biol Chem 2002 May 24;277(21):18961-6.
3. Growth hormone (GH) action in the developing lung: changes in lung proteins after adenoviral GH overexpression. Beyea JA, etal., Dev Dyn. 2005 Oct;234(2):404-12.
4. Capturing proteins that bind polyunsaturated fatty acids: demonstration using arachidonic acid and eicosanoids. Brock TG Lipids. 2008 Feb;43(2):161-9. Epub 2007 Dec 15.
5. Recombinant rat nucleoside diphosphate kinase isoforms (alpha and beta): purification, properties and application to immunological detection of native isoforms in rat tissues. Fukuchi T, etal., Biochim Biophys Acta. 1994 Mar 16;1205(1):113-22.
6. Decreased expression of nucleoside diphosphate kinase alpha isoform, an nm23-H2 gene homolog, is associated with metastatic potential of rat mammary-adenocarcinoma cells. Fukuda M, etal., Int J Cancer. 1996 Feb 8;65(4):531-7.
7. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
8. Oligomeric structure and autophosphorylation of nucleoside diphosphate kinase from rat mucosal mast cells. Hemmerich S and Pecht I, Biochemistry. 1992 May 19;31(19):4580-7.
9. A cromoglycate binding protein from rat mast cells of a leukemia line is a nucleoside diphosphate kinase. Hemmerich S, etal., Biochemistry 1992 May 19;31(19):4574-9.
10. Regulation of cardiac cAMP synthesis and contractility by nucleoside diphosphate kinase B/G protein beta gamma dimer complexes. Hippe HJ, etal., Circ Res. 2007 Apr 27;100(8):1191-9. Epub 2007 Mar 15.
11. De novo synthesis of pyrimidine nucleotides; emerging interfaces with signal transduction pathways. Huang M and Graves LM, Cell Mol Life Sci. 2003 Feb;60(2):321-36.
12. Overexpression of nucleoside diphosphate kinases induces neurite outgrowth and their substitution to inactive forms leads to suppression of nerve growth factor- and dibutyryl cyclic AMP-induced effects in PC12D cells. Ishijima Y, etal., FEBS Lett. 1999 Feb 19;445(1):155-9.
13. M-LDH serves as a regulatory subunit of the cytosolic substrate-channelling complex in vivo. Jovanovic S, etal., J Mol Biol. 2007 Aug 10;371(2):349-61. Epub 2007 Jun 2.
14. Analysis of nm23 gene expressions in human bladder and renal cancers. Kanayama H, etal., Int J Urol. 1994 Dec;1(4):324-31.
15. NM23-H2 involves in negative regulation of Diva and Bcl2L10 in apoptosis signaling. Kang Y, etal., Biochem Biophys Res Commun. 2007 Jul 20;359(1):76-82. doi: 10.1016/j.bbrc.2007.05.090. Epub 2007 May 24.
16. KEGG: Kyoto Encyclopedia of Genes and Genomes KEGG
17. Isolation and characterization of a cDNA clone encoding rat nucleoside diphosphate kinase. Kimura N, etal., J Biol Chem 1990 Sep 15;265(26):15744-9.
18. Expression of nm23-H1 and nm23-H2 proteins in prostate carcinoma. Konishi N, etal., Jpn J Cancer Res. 1993 Oct;84(10):1050-4.
19. Localization and characterization of the mitochondrial isoform of the nucleoside diphosphate kinase in the pancreatic beta cell: evidence for its complexation with mitochondrial succinyl-CoA synthetase. Kowluru A, etal., Arch Biochem Biophys. 2002 Feb 15;398(2):160-9.
20. The human Nm23/nucleoside diphosphate kinases. Lacombe ML, etal., J Bioenerg Biomembr. 2000 Jun;32(3):247-58.
21. Increased activity of membrane-associated nucleoside diphosphate kinase and inhibition of cAMP synthesis in failing human myocardium. Lutz S, etal., Cardiovasc Res. 2001 Jan;49(1):48-55.
22. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Mandai M, etal., Cancer Res. 1994 Apr 1;54(7):1825-30.
23. Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion. Marone M, etal., Br J Cancer. 1996 Oct;74(7):1063-8.
24. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
25. Allelic loss and somatic differentiation in human male germ cell tumors. Murty VV, etal., Oncogene. 1994 Aug;9(8):2245-51.
26. Electronic Transfer of LocusLink and RefSeq Data NCBI rat LocusLink and RefSeq merged data July 26, 2002
27. Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23. Ohkura N, etal., Biochem Biophys Res Commun. 2001 Apr 20;282(5):1206-10.
28. A new function of Nm23/NDP kinase as a differentiation inhibitory factor, which does not require it's kinase activity. Okabe-Kado J, etal., FEBS Lett. 1995 Apr 24;363(3):311-5.
29. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
30. SMPDB Annotation Import Pipeline Pipeline to import SMPDB annotations from SMPDB into RGD
31. NM23-H2, an estrogen receptor beta-associated protein, shows diminished expression with progression of atherosclerosis. Rayner K, etal., Am J Physiol Regul Integr Comp Physiol. 2007 Feb;292(2):R743-50. Epub 2006 Aug 3.
32. GOA pipeline RGD automated data pipeline
33. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
34. Activated microglia modulate astroglial enzymes involved in oxidative and inflammatory stress and increase the resistance of astrocytes to oxidative stress in vitro. Rohl C, etal., Glia. 2008 Aug 1;56(10):1114-26.
35. Nucleoside diphosphate kinase beta (Nm23-R1/NDPKbeta) is associated with intermediate filaments and becomes upregulated upon cAMP-induced differentiation of rat C6 glioma. Roymans D, etal., Exp Cell Res. 2000 Nov 25;261(1):127-38.
36. Alterations of the metastasis suppressor gene nm23 and the proto-oncogene c-myc in human testicular germ cell tumors. Schmidt B, etal., J Urol. 1997 Nov;158(5):2000-5.
37. Reduced metastatic potential and c-myc overexpression of colon adenocarcinoma cells (Colon 26 line) transfected with nm23-R2/rat nucleoside diphosphate kinase alpha isoform. Tagashira H, etal., Int J Mol Med. 1998 Jul;2(1):65-8.
38. Low cytosine triphosphate synthase 2 expression renders resistance to 5-fluorouracil in colorectal cancer. Tan WL, etal., Cancer Biol Ther. 2011 Mar 15;11(6):599-608. Epub 2011 Mar 15.
39. Gamendazole, an orally active indazole carboxylic acid male contraceptive agent, targets HSP90AB1 (HSP90BETA) and EEF1A1 (eEF1A), and stimulates Il1a transcription in rat Sertoli cells. Tash JS, etal., Biol Reprod. 2008 Jun;78(6):1139-52. doi: 10.1095/biolreprod.107.062679. Epub 2008 Jan 23.
40. Down-regulation of expression and function of nucleoside diphosphate kinase in insulin-secreting beta-cells under in vitro conditions of glucolipotoxicity. Veluthakal R, etal., Mol Cell Biochem. 2009 Sep;329(1-2):121-9. Epub 2009 Apr 15.
41. Expression of nm23-H1 and nm23-H2 protein in endometrial carcinoma. Watanabe J, etal., Br J Cancer. 1995 Dec;72(6):1469-73.
42. Mapping the high-affinity binding domain of 5-substituted benzimidazoles to the proximal N-terminus of the GluN2B subunit of the NMDA receptor. Wee XK, etal., Br J Pharmacol. 2010 Jan 1;159(2):449-61. Epub 2010 Jan 15.
43. 12-O-tetradecanoylphorbol-13-acetate and UV radiation-induced nucleoside diphosphate protein kinase B mediates neoplastic transformation of epidermal cells. Wei SJ, etal., J Biol Chem. 2004 Feb 13;279(7):5993-6004. Epub 2003 Nov 17.
Additional References at PubMed
PMID:1321145   PMID:1851158   PMID:8392752   PMID:11277919   PMID:11919189   PMID:12477932   PMID:12972261   PMID:14651853   PMID:15489334   PMID:15616584   PMID:15703214   PMID:16862176  
PMID:17634366   PMID:18614015   PMID:19199708   PMID:19435876   PMID:20458337   PMID:21111809   PMID:21630459   PMID:22817458   PMID:22871113   PMID:23368879   PMID:23533145   PMID:25679041  


Genomics

Comparative Map Data
Nme2
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81079,394,999 - 79,400,418 (-)NCBIGRCr8
mRatBN7.21078,898,097 - 78,903,514 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1078,897,770 - 78,903,538 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1083,508,941 - 83,514,439 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01083,007,040 - 83,012,538 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01078,478,407 - 78,483,899 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01081,648,216 - 81,653,717 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1081,648,216 - 81,653,717 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01081,478,178 - 81,483,679 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41082,582,766 - 82,588,269 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11082,597,135 - 82,602,639 (-)NCBI
Celera1077,694,496 - 77,700,026 (-)NCBICelera
Cytogenetic Map10q26NCBI
NME2
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381751,165,536 - 51,171,744 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1751,165,435 - 51,171,744 (+)EnsemblGRCh38hg38GRCh38
GRCh371749,242,897 - 49,249,105 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 361746,597,890 - 46,604,104 (+)NCBINCBI36Build 36hg18NCBI36
Build 341746,598,810 - 46,604,103NCBI
Celera1745,704,144 - 45,710,358 (+)NCBICelera
Cytogenetic Map17q21.33NCBI
HuRef1744,612,062 - 44,618,375 (+)NCBIHuRef
CHM1_11749,307,431 - 49,313,740 (+)NCBICHM1_1
T2T-CHM13v2.01752,032,848 - 52,039,047 (+)NCBIT2T-CHM13v2.0
Nme2
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm391193,840,640 - 93,847,082 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1193,840,640 - 93,847,085 (-)EnsemblGRCm39 Ensembl
GRCm381193,949,814 - 93,956,256 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1193,949,814 - 93,956,259 (-)EnsemblGRCm38mm10GRCm38
MGSCv371193,811,129 - 93,817,321 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv361193,765,904 - 93,772,097 (-)NCBIMGSCv36mm8
Celera11103,564,861 - 103,571,040 (-)NCBICelera
Cytogenetic Map11DNCBI
cM Map1158.88NCBI
NME2
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v21967,353,449 - 67,359,441 (+)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan11772,160,643 - 72,166,512 (+)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v01745,255,982 - 45,261,541 (+)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.11750,126,867 - 50,131,776 (+)NCBIpanpan1.1PanPan1.1panPan2
NME2
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1927,002,114 - 27,005,740 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl927,001,733 - 27,015,934 (+)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha926,330,716 - 26,333,823 (+)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0927,795,956 - 27,799,595 (+)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl927,795,346 - 27,799,595 (+)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1926,562,504 - 26,565,610 (+)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0926,822,054 - 26,825,171 (+)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0926,952,138 - 26,955,247 (+)NCBIUU_Cfam_GSD_1.0
Nme2
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_02440560226,435,190 - 26,440,351 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_00493649010,633,454 - 10,649,914 (-)EnsemblSpeTri2.0SpeTri2.0 Ensembl
SpeTri2.0NW_00493649010,634,788 - 10,640,182 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
NME2
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl1227,439,260 - 27,445,027 (+)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.11227,439,529 - 27,445,025 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.21227,507,399 - 27,513,382 (+)NCBISscrofa10.2Sscrofa10.2susScr3
LOC103242911
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.11642,176,690 - 42,182,041 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl1642,176,524 - 42,182,019 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_02366607712,886,379 - 12,891,712 (-)NCBIVero_WHO_p1.0Vero_WHO_p1.0

Variants

.
Variants in Nme2
11 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:29
Count of miRNA genes:28
Interacting mature miRNAs:29
Transcripts:ENSRNOT00000003611
Prediction methods:Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
70223Bp57Blood pressure QTL 575arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)10180676123Rat
61427Cia16Collagen induced arthritis QTL 163.2joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)10635789696121100Rat
2303118Mamtr7Mammary tumor resistance QTL 70.003mammary gland integrity trait (VT:0010552)mammary tumor growth rate (CMO:0000344)109658275104670812Rat
2301967Cm73Cardiac mass QTL 734.55heart left ventricle mass (VT:0007031)heart left ventricle weight to body weight ratio (CMO:0000530)101448701189062041Rat
631268Cia21Collagen induced arthritis QTL 213.1joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1014487011104060283Rat
2316949Gluco60Glucose level QTL 603.7blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)1014487011107057807Rat
1554317Bmd4Bone mineral density QTL 49.40.0001lumbar vertebra mineral mass (VT:0010511)volumetric bone mineral density (CMO:0001553)101981604299406971Rat
724556Pur2Proteinuria QTL 25.5urine protein amount (VT:0005160)urine protein level (CMO:0000591)102242750090627625Rat
61354Pia10Pristane induced arthritis QTL 100.01joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1023444813104060283Rat
631267Cia20Collagen induced arthritis QTL 203.2joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1023444813104060283Rat
61325Aia5Adjuvant induced arthritis QTL 50.01joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1023444813104060283Rat
1298069Bp168Blood pressure QTL 1685.5blood pressure trait (VT:0000183)systolic blood pressure (CMO:0000004)102652195798003205Rat
631542Bp82Blood pressure QTL 826.8arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)102652195798952741Rat
1331791Cm31Cardiac mass QTL 313.84606heart mass (VT:0007028)heart wet weight (CMO:0000069)1029299504107211142Rat
1576319Cia29Collagen induced arthritis QTL 29joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)103397392178973921Rat
2317042Aia20Adjuvant induced arthritis QTL 203.38joint integrity trait (VT:0010548)right rear ankle joint diameter (CMO:0002150)103756507982565079Rat
2317043Aia7Adjuvant induced arthritis QTL 73.82joint integrity trait (VT:0010548)left rear ankle joint diameter (CMO:0002149)103756507982565079Rat
1576308Schws1Schwannoma susceptibility QTL 10.0041nervous system integrity trait (VT:0010566)percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017)1040035094102359817Rat
631269Cia22Collagen induced arthritis QTL 228.9joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1040035094104060283Rat
631270Cia23Collagen induced arthritis QTL 233.9joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1040035094104060283Rat
631552Vetf2Vascular elastic tissue fragility QTL 24.50.0002aorta elastic tissue integrity trait (VT:0010556)artery internal elastic lamina non-tumorous lesion count (CMO:0001913)104114263386142633Rat
61463Bp12Blood pressure QTL 126.30.0001arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)104133325886333258Rat
1298078Stresp5Stress response QTL 52.990.00025blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)1042045676104670812Rat
70188BpQTLcluster1Blood pressure QTL cluster 14.864arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)14232313287323132Rat
70188BpQTLcluster1Blood pressure QTL cluster 14.864arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)14232313287323132Rat
70188BpQTLcluster1Blood pressure QTL cluster 14.864arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)14232313287323132Rat
70188BpQTLcluster1Blood pressure QTL cluster 14.864arterial blood pressure trait (VT:2000000)pulse pressure (CMO:0000292)14232313287323132Rat
70198BpQTLcluster9Blood pressure QTL cluster 92.94arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)104232313287323132Rat
6893342Cm78Cardiac mass QTL 780.10.88heart mass (VT:0007028)heart weight to body weight ratio (CMO:0000074)104287676679813922Rat
9589030Epfw9Epididymal fat weight QTL 919.240.001epididymal fat pad mass (VT:0010421)epididymal fat pad weight to body weight ratio (CMO:0000658)104444169989441699Rat
7411614Foco18Food consumption QTL 180.001eating behavior trait (VT:0001431)feed conversion ratio (CMO:0001312)104444169989441699Rat
8694173Bw149Body weight QTL 1494.380.001body mass (VT:0001259)body weight gain (CMO:0000420)104444169989441699Rat
2300218Hpcl2Hepatic cholesterol level QTL 2liver cholesterol amount (VT:0010498)liver cholesterol level (CMO:0001597)104502965095600334Rat
631547Bp87Blood pressure QTL 874.5arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)104736947092369470Rat
2293705Bmd25Bone mineral density QTL 257.10.0001femur mineral mass (VT:0010011)compact volumetric bone mineral density (CMO:0001730)104944455181709989Rat
7207811Bmd90Bone mineral density QTL 905.2femur size trait (VT:1000369)femoral neck cross-sectional area (CMO:0001697)104944455181709989Rat
2293652Bmd22Bone mineral density QTL 224.90.0001femur mineral mass (VT:0010011)total volumetric bone mineral density (CMO:0001728)104944455181709989Rat
2293669Bmd33Bone mineral density QTL 334.50.0001femur strength trait (VT:0010010)femoral neck polar moment of inertia (CMO:0001670)104944455181709989Rat
2293679Bmd30Bone mineral density QTL 303.50.0001femur mineral mass (VT:0010011)total volumetric bone mineral density (CMO:0001728)104944455181709989Rat
1549846Scl47Serum cholesterol level QTL 473.6blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)105057470795574707Rat
70364Bp72Blood pressure QTL 72arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)105112110096121100Rat
61387Bp1Blood pressure QTL 15.1arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1051770177107211142Rat
61387Bp1Blood pressure QTL 15.1arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)1051770177107211142Rat
1359017Hrtrt21Heart rate QTL 212.4heart pumping trait (VT:2000009)heart rate (CMO:0000002)105177294096772940Rat
631530Tls3T-lymphoma susceptibility QTL 300.0001thymus integrity trait (VT:0010555)percentage of study population developing T-cell lymphomas during a period of time (CMO:0001911)105177461295600334Rat
631535Cm51Cardiac mass QTL 513heart mass (VT:0007028)calculated heart weight (CMO:0000073)105178628291669536Rat
70171Cari1Carrageenan-induced inflammation QTL 14.90.0005hypodermis integrity trait (VT:0010550)inflammatory exudate volume (CMO:0001429)1053797385107211142Rat
70164Bw21Body weight QTL 214.360.00005body mass (VT:0001259)body weight (CMO:0000012)105379749498952626Rat
1354608Cm33Cardiac mass QTL 332.8heart left ventricle mass (VT:0007031)heart left ventricle wet weight (CMO:0000071)105480929299809292Rat
2312662Slep8Serum leptin concentration QTL 80.05blood leptin amount (VT:0005667)serum leptin level (CMO:0000780)1057134272102134272Rat
2312668Scl65Serum cholesterol level QTL 650.001blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)1057134272102134272Rat
2312672Insul15Insulin level QTL 150.01blood insulin amount (VT:0001560)serum insulin level (CMO:0000358)1057134272102134272Rat
1549831Bss6Bone structure and strength QTL 64lumbar vertebra strength trait (VT:0010574)vertebra ultimate force (CMO:0001678)1057576521102576521Rat
2293698Bss43Bone structure and strength QTL 435.330.0001lumbar vertebra size trait (VT:0010518)lumbar vertebra cross-sectional area (CMO:0001689)1059209888104209888Rat
70363Bp71Blood pressure QTL 710.04arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)106134527681714865Rat
2306970Anxrr22Anxiety related response QTL 225.95fear/anxiety-related behavior trait (VT:1000241)number of periods of voluntary immobility (CMO:0001045)106134527698211570Rat
6893336Cm75Cardiac mass QTL 750.10.87heart mass (VT:0007028)heart weight to body weight ratio (CMO:0000074)106134527699703528Rat
1558643Cm44Cardiac mass QTL 444.80.0000368heart mass (VT:0007028)heart wet weight (CMO:0000069)106134527699703528Rat
61402Niddm3Non-insulin dependent diabetes mellitus QTL 34.58blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)106134541382564856Rat
2313103Bss80Bone structure and strength QTL 8020.0001tibia strength trait (VT:1000284)tibia midshaft endosteal cross-sectional area (CMO:0001716)1062057807107057807Rat
2313105Bss79Bone structure and strength QTL 791.80.0001tibia size trait (VT:0100001)tibia midshaft cross-sectional area (CMO:0001717)1062057807107057807Rat
61449Ciaa2CIA Autoantibody QTL 27.1blood autoantibody amount (VT:0003725)calculated serum anti-type 2 collagen antibody titer (CMO:0001279)1063221094107211142Rat
2298481Eau9Experimental allergic uveoretinitis QTL 90.0169uvea integrity trait (VT:0010551)experimental autoimmune uveitis score (CMO:0001504)106592723382565079Rat
1357344Bp249Blood pressure QTL 2490.0001arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)106674365598003205Rat
2317029Aia19Adjuvant induced arthritis QTL 192.98joint integrity trait (VT:0010548)left rear ankle joint diameter (CMO:0002149)1066978955107211142Rat
2317039Aia6Adjuvant induced arthritis QTL 64.31joint integrity trait (VT:0010548)right rear ankle joint diameter (CMO:0002150)1066978955107211142Rat
10450498Bp384Blood pressure QTL 3840.002arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1067750049107211142Rat
1642980Bp300Blood pressure QTL 300arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1068383129107211142Rat
61396Bp9Blood pressure QTL 94.80.0001arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1068420376107211142Rat
2300172Bmd57Bone mineral density QTL 579.80.0001femur mineral mass (VT:0010011)volumetric bone mineral density (CMO:0001553)1069738412107211142Rat
2293646Bss25Bone structure and strength QTL 2510.960.0001femur morphology trait (VT:0000559)femur cross-sectional area (CMO:0001661)1069738412107211142Rat
2293663Bss33Bone structure and strength QTL 339.340.0001femur strength trait (VT:0010010)femur midshaft polar moment of inertia (CMO:0001669)1069738412107211142Rat
6893366Bw106Body weight QTL 1060.30.47body mass (VT:0001259)body weight (CMO:0000012)1070199100107211142Rat
70193Mcs7Mammary carcinoma susceptibility QTL 72.38mammary gland integrity trait (VT:0010552)mammary tumor number (CMO:0000343)1072224939107211142Rat
2298548Neuinf7Neuroinflammation QTL 73.4nervous system integrity trait (VT:0010566)spinal cord RT1-B protein level (CMO:0002132)1072224939107211142Rat
2306793Ean5Experimental allergic neuritis QTL 54.7nervous system integrity trait (VT:0010566)IFNG-secreting splenocyte count (CMO:0002122)107255241693995749Rat
12880053Cm104Cardiac mass QTL 1040.009heart right ventricle mass (VT:0007033)heart right ventricle weight to body weight ratio (CMO:0000914)107345299283463334Rat
1358188Ept9Estrogen-induced pituitary tumorigenesis QTL 93.9pituitary gland mass (VT:0010496)pituitary gland wet weight (CMO:0000853)107345313696120911Rat
2292617Ept18Estrogen-induced pituitary tumorigenesis QTL 183.9pituitary gland mass (VT:0010496)pituitary gland wet weight (CMO:0000853)107345313696120911Rat
12880050Am10Aortic mass QTL 100.016aorta mass (VT:0002845)aorta weight to aorta length to body weight ratio (CMO:0002722)107437208484007272Rat
1579919Bp281Blood pressure QTL 2810.01arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)107437208494965338Rat
631537Oia4Oil induced arthritis QTL 4joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)107563188787055282Rat
2325836Bp346Blood pressure QTL 3460.001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)107624608584007272Rat
10450495Bp383Blood pressure QTL 3830.002arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)107624608594965338Rat
2292438Bp311Blood pressure QTL 311arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)1076246085107211142Rat
1302404Cia27Collagen induced arthritis QTL 272.60.0045joint integrity trait (VT:0010548)experimental arthritis severity measurement (CMO:0001459)1076452683107211142Rat
4889492Pancm2Pancreatic morphology QTL 23.2pancreatic beta cell morphology trait (VT:0005217)ratio of insulin-positive cell area to total area of splenic region of pancreas (CMO:0001814)1076748906107211142Rat
724516Uae17Urinary albumin excretion QTL 173.6urine albumin amount (VT:0002871)urine albumin excretion rate (CMO:0000757)107821062285220348Rat
1300107Rf18Renal function QTL 183.41urine output (VT:0003620)timed urine volume (CMO:0000260)107877551698279596Rat
1358915Stresp7Stress response QTL 73.52blood norepinephrine amount (VT:0005663)plasma norepinephrine level (CMO:0001010)107889965587307728Rat

Markers in Region
D10Mgh23  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21078,899,655 - 78,899,894 (+)MAPPERmRatBN7.2
mRatBN7.21078,899,655 - 78,899,805 (+)MAPPERmRatBN7.2
Rnor_6.01081,649,775 - 81,649,924NCBIRnor6.0
Rnor_6.01081,649,775 - 81,650,013NCBIRnor6.0
Rnor_5.01081,479,737 - 81,479,975UniSTSRnor5.0
Rnor_5.01081,479,737 - 81,479,886UniSTSRnor5.0
RGSC_v3.11082,598,694 - 82,598,844RGD
Celera1077,696,055 - 77,696,204UniSTS
Celera1077,696,055 - 77,696,293UniSTS
RH 2.0 Map10835.7RGD
Cytogenetic Map10q26UniSTS
RH135179  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21078,902,553 - 78,902,753 (+)MAPPERmRatBN7.2
Rnor_6.01081,652,671 - 81,652,870NCBIRnor6.0
Rnor_5.01081,482,633 - 81,482,832UniSTSRnor5.0
RGSC_v3.41082,587,223 - 82,587,422UniSTSRGSC3.4
Celera1077,698,980 - 77,699,179UniSTS
RH 3.4 Map10631.4UniSTS
Cytogenetic Map10q26UniSTS
PMC312758P3  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21078,903,324 - 78,903,444 (+)MAPPERmRatBN7.2
Rnor_6.01081,653,442 - 81,653,561NCBIRnor6.0
Rnor_5.01081,483,404 - 81,483,523UniSTSRnor5.0
RGSC_v3.41082,587,994 - 82,588,113UniSTSRGSC3.4
Celera1077,699,751 - 77,699,870UniSTS
Cytogenetic Map10q26UniSTS


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system appendage
High 5 2 2 2
Medium 3 38 55 39 19 39 8 11 74 35 41 11 8
Low
Below cutoff

Sequence


RefSeq Acc Id: ENSRNOT00000003611   ⟹   ENSRNOP00000003611
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1078,897,770 - 78,903,538 (-)Ensembl
Rnor_6.0 Ensembl1081,648,216 - 81,653,717 (-)Ensembl
RefSeq Acc Id: NM_031833   ⟹   NP_114021
RefSeq Status: VALIDATED
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81079,394,999 - 79,400,418 (-)NCBI
mRatBN7.21078,898,097 - 78,903,514 (-)NCBI
Rnor_6.01081,648,216 - 81,653,717 (-)NCBI
Rnor_5.01081,478,178 - 81,483,679 (-)NCBI
RGSC_v3.41082,582,766 - 82,588,269 (-)RGD
Celera1077,694,496 - 77,700,026 (-)RGD
Sequence:
RefSeq Acc Id: NP_114021   ⟸   NM_031833
- UniProtKB: P19804 (UniProtKB/Swiss-Prot),   A6HI34 (UniProtKB/TrEMBL),   A0A8I6A4T4 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSRNOP00000003611   ⟸   ENSRNOT00000003611
Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P19804-F1-model_v2 AlphaFold P19804 1-152 view protein structure

Transcriptome

eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

Promoters
RGD ID:13697598
Promoter ID:EPDNEW_R8121
Type:initiation region
Name:Nme2_1
Description:NME/NM23 nucleoside diphosphate kinase 2
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Rat AssemblyChrPosition (strand)Source
Rnor_6.01081,653,604 - 81,653,664EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:619877 AgrOrtholog
BIND 129608
BioCyc Gene G2FUF-23638 BioCyc
BioCyc Pathway PWY-7176 [UTP and CTP de novo biosynthesis] BioCyc
  PWY-7184 [pyrimidine deoxyribonucleotides de novo biosynthesis I] BioCyc
  PWY-7197 [pyrimidine deoxyribonucleotide phosphorylation] BioCyc
  PWY-7205 [CMP phosphorylation] BioCyc
  PWY-7210 [pyrimidine deoxyribonucleotides biosynthesis from CTP] BioCyc
  PWY-7221 [guanosine ribonucleotides de novo biosynthesis] BioCyc
  PWY-7224 [purine deoxyribonucleosides salvage] BioCyc
  PWY-7226 [guanosine deoxyribonucleotides de novo biosynthesis I] BioCyc
  PWY-7227 [adenosine deoxyribonucleotides de novo biosynthesis I] BioCyc
BioCyc Pathway Image PWY-7176 BioCyc
  PWY-7184 BioCyc
  PWY-7197 BioCyc
  PWY-7205 BioCyc
  PWY-7210 BioCyc
  PWY-7221 BioCyc
  PWY-7224 BioCyc
  PWY-7226 BioCyc
  PWY-7227 BioCyc
Ensembl Genes ENSRNOG00000001226 UniProtKB/TrEMBL
  ENSRNOG00000002671 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
  ENSRNOG00055032669 UniProtKB/Swiss-Prot
  ENSRNOG00060030273 UniProtKB/Swiss-Prot
  ENSRNOG00065018324 UniProtKB/Swiss-Prot
Ensembl Transcript ENSRNOT00000003611 ENTREZGENE
  ENSRNOT00000003611.4 UniProtKB/Swiss-Prot
  ENSRNOT00000037297.5 UniProtKB/TrEMBL
  ENSRNOT00055056453 UniProtKB/Swiss-Prot
  ENSRNOT00060052572 UniProtKB/Swiss-Prot
  ENSRNOT00065030712 UniProtKB/Swiss-Prot
Gene3D-CATH 3.30.70.141 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
IMAGE_CLONE IMAGE:7312852 IMAGE-MGC_LOAD
InterPro NDK-like_dom UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  NDK-like_dom_sf UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Nucleoside_diP_kinase UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Nucleoside_diP_kinase_AS UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report rno:83782 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
MGC_CLONE MGC:105386 IMAGE-MGC_LOAD
NCBI Gene 83782 ENTREZGENE
PANTHER NUCLEOSIDE DIPHOSPHATE KINASE UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  NUCLEOSIDE DIPHOSPHATE KINASE B UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam NDK UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PhenoGen Nme2 PhenoGen
PRINTS NUCDPKINASE UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PROSITE NDP_KINASES UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
RatGTEx ENSRNOG00000001226 RatGTEx
  ENSRNOG00000002671 RatGTEx
  ENSRNOG00055032669 RatGTEx
  ENSRNOG00060030273 RatGTEx
  ENSRNOG00065018324 RatGTEx
SMART NDK UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Superfamily-SCOP Nucleoside diphosphate kinase, NDK UniProtKB/TrEMBL, UniProtKB/Swiss-Prot
UniProt A0A8I6A4T4 ENTREZGENE, UniProtKB/TrEMBL
  A6HI34 ENTREZGENE, UniProtKB/TrEMBL
  NDKB_RAT UniProtKB/Swiss-Prot, ENTREZGENE


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2012-10-05 Nme2  NME/NM23 nucleoside diphosphate kinase 2  Nme2  non-metastatic cells 2, protein (NM23B) expressed in  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2008-05-15 Nme2  non-metastatic cells 2, protein (NM23B) expressed in  Nme2  expressed in non-metastatic cells 2  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2005-01-20 Nme2  expressed in non-metastatic cells 2    nucleoside diphosphate kinase  Name updated 1299863 APPROVED
2002-08-07 Nme2  nucleoside diphosphate kinase      Symbol and Name status set to provisional 70820 PROVISIONAL